Providing market research reports, industry analysis, company profiles and country reports for strategic planning, competitive intelligence, marketing and business research.
Search for Market Research Reports:    

U.S. Peripheral Vascular Stent and Stent Grafts Markets

Published by: Frost & Sullivan

Published: Jul. 10, 2006 - 101 Pages



Table of Contents


1. Executive Summary
 1. Executive Summary
  1. Executive Summary

2. Total U.S. Peripheral Vascular Stent and Stent Grafts Market
 1. Market Overview
  1. Overview
  2. Scope and Segmentation
  3. Definitions and Abbreviations
 2. Challenges and Strategies
  1. Industry Challenges
  2. Strategies
 3. Market Forecasts and Analysis
  1. Market Engineering Measurements
  2. Total Revenue Forecasts
 4. Competitive Analysis
  1. Competitive Structure
  2. Competitive Factors
  3. Distribution Structure
  4. Key End-user Group
  5. Market Share Analysis
 5. Technology and Market Trends
  1. Emerging Technologies
  2. Mergers and Acquisitions
  3. Company Analysis
  4. Reimbursement Trends
  5. Regulatory Trends
 6. Frost and Sullivan Awards for Peripheral Stent and Stent Grafts Market
  1. Market Leadership
  2. Excellence in Technology
  3. Product Innovation

3. Aortic Aneurysm Stent Grafts Market
 1. Market Forecasts and Analysis
  1. Market Overview
  2. Market Drivers
  3. Market Restraints
  4. Market Engineering Measurements
  5. Revenue Forecasts
  6. Procedure Forecasts
 2. Competitive Analysis
  1. Competitive Structure
  2. Market Share Analysis
  3. Product Analysis

4. Renal Iliac and Biliary Stents Market
 1. Market Forecast and Analysis
  1. Market Overview
  2. Market Drivers
  3. Market Restraints
  4. Market Engineering Measurements
  5. Revenue Forecasts
 2. Competitive Analysis
  1. Competitive Structure
  2. Market Share Analysis
  3. Product Analysis

5. Femoral-Popliteal Stent Market
 1. Market Forecast and Analysis
  1. Market Overview
  2. Market Drivers
  3. Market Restraints
  4. Market Engineering Measurements
  5. Revenue Forecasts
  6. Device Usage Forecast
 2. Competitive Analysis
  1. Competitive Structure
  2. Market Share Analysis
  3. Product Analysis

6. Decision Support Databases
 1. Decision Support Databases
  1. Population 65 and above
  2. Obesity Rates
  3. Hospitals
  4. Cardiovascular Mortality
  5. Number of Cardiologists
  6. Cerebrovascular Mortality
  7. Cerbrovasular Hospital Discharge



List of Figures



SEGMENT 2


  • Peripheral Vascular Stent and Stent Grafts Market: Challenges and Corresponding Strategic Recommendations (U.S.), 2006-2012

  • Peripheral Vascular Stent and Stent Grafts Market: Revenue Forecasts (U.S.), 2002-2012

  • Peripheral Vascular Stent and Stent Grafts Market: Competitive Structure (U.S.), 2005

  • Peripheral Vascular Stent and Stent Grafts Market: Market Share Trends of Major Market Participants (U.S.), 2005


SEGMENT 3

  • Aortic Aneurysm Stent Grafts Market: Market Drivers Ranked in Order of Impact (U.S.), 2006-2012

  • Aortic Aneurysm Stent Grafts Market: Market Restraints Ranked in Order of Impact (U.S.), 2006-2012

  • Aortic Aneurysm Stent Grafts Market: Revenue Forecasts (U.S.), 2002-2012

  • Aortic Aneurysm Stent Grafts Market: Procedure and Market Penetration Rate (U.S.), 2002-2012

  • Aortic Aneurysm Stent Grafts Market: Competitive Structure (U.S.), 2005

  • Aortic Aneurysm Stent Grafts Market: Market Share Trends of Major Market Participants (U.S.), 2005


SEGMENT 4

  • Renal, Iliac, and Biliary Stents Market: Market Drivers Ranked in Order of Impact (U.S.), 2006-2012

  • Renal, Iliac, and Biliary Stents Market: Market Restraints Ranked in Order of Impact (U.S.), 2006-2012

  • Renal, Iliac, and Biliary Stents Market: Revenue Forecasts (U.S.), 2002-2012

  • Renal, Iliac, and Biliary Stents Market: Competitive Structure (U.S.), 2005

  • Renal, Iliac, and Biliary Stents Market: Market Share Trends of Major Market Participants (U.S.), 2005


SEGMENT 5

  • Femoral-Popliteal Stent Market: Market Drivers Ranked in Order of Impact (U.S.), 2006-2012

  • Femoral-Popliteal Stent Market: Market Restraints Ranked in Order of Impact (U.S.), 2006-2012

  • Femoral-Popliteal Stent Market: Revenue Forecasts (U.S.), 2002-2012

  • Femoral-Popliteal Stent Market: Stent Numbers and Market Penetration Rate (U.S.), 2002-2012

  • Femoral-Popliteal Stent Market: Competitive Structure (U.S.), 2005

  • Femoral-Popliteal Stent Market: Market Share Trends of Major Market Participants (U.S.), 2005

Abstract

Research Overview

This Frost & Sullivan research service entitled U.S. Peripheral Vascular Stent and Stent Grafts Market provides an overview of the trends and technologies that have shaped market revenue, market share, and implantation rates in the individual segments of the market. In this research, Frost & Sullivan's expert analysts thoroughly examine the following markets: Aortic Aneurysms Grafts, Renal, Iliac, and Biliary stents, in addition to stents used in the lower extremity, including foropopliteal arteries and below the leg.

Market Sectors

Expert Frost & Sullivan analysts thoroughly examine the following market sectors in this analysis:
  • Cardiovascular Devices
  • Stents
Technologies

The following technologies are covered in this research:
  • Self Expanding Stents
  • Bioadsorbable
  • Rapid Exchange
  • Microcoils
  • Liquid Embolics
Market Overview

Due to the plethora of devices with similar features vying for the market, being able to develop a robust technologically advanced product line will be critical to improving the chance a device witnesses high levels of success upon launch.

In the peripheral stent market, the development of next generation technology such as drug eluting capabilities, in situ stent control or bioadsorbable device, each technological feature has a significant benefit to reducing the risk of restenosis and improving the ease of implantation. Developing and launching a device that fails to offer a significant benefit over competing devices, forces that device to compete against a high degree of negative market challenges. Firms need to make themselves aware of the features that will best serve the market six to seven years down the line, when those products would have completed regulatory approval and be ready for market launch.

Being able to control the length of a stent in-situ for lesion sites that vary to the degree femoral occlusions do, will have a marked advantage over having to estimate the lesion size before hand. Bio-adsorbable devices also pose an obvious longterm advantage, in that the stent dissolves away after its usefulness. Standard metallic stents after the length of their intended use, actually are a risk factor for leading to vessel occlusion. Among those features, optimization of future product lines will be a major advantage to future market competitiveness.

Stenting and grafts are increasingly transitioning into the gold standard for combating peripheral vascular diseases (PVD). An underserved market with high rates of disability and morbidity represents a significant market opportunity for market participants to develop and launch novel medical stents customized for the intricacies of the peripheral vasculature. The long term clinical success rates, in addition to the titanic revenue streams generated by the coronary stent market have sparked significant interest in their sister devices.

Get Full Details About This Report >>
US: 800.298.5699
Int'l: +1.240.747.3093
Buy this Report

Price and Delivery Options
See related reports or call the number above for help from a research specialist.


 

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.

 

© MarketResearch.com 2008